Cargando…
Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880207/ https://www.ncbi.nlm.nih.gov/pubmed/36712251 http://dx.doi.org/10.3389/fcvm.2022.1070336 |
_version_ | 1784878856865316864 |
---|---|
author | Chen, Yiru Cao, Buzi Zhou, Quan Liu, Yantong He, Qingnan Zhao, Mingyi |
author_facet | Chen, Yiru Cao, Buzi Zhou, Quan Liu, Yantong He, Qingnan Zhao, Mingyi |
author_sort | Chen, Yiru |
collection | PubMed |
description | OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publications and used different types of software, such as R, CiteSpace, and VOSviewer, to analyze and visualize the data. RESULTS: A total of 10,055 publications were retrieved as of the 13 December 2022, based on the inclusion criteria after screening. The USA and China lead in the quantity and quality of publications in this field. Based on Bradford's law, 63 journals were considered core journals in the field. Co-cited references and keywords analysis indicated that researchers paid particular attention to cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. In summary, with increasing COVID-19 research related to CVD, more attention might be drawn to the relationship between these two diseases. CONCLUSION: The hotspots in this field may continue to revolve around cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. Owing to the different situations faced by different groups with COVID-19, further exploration of the related factors specific to each of these groups, e.g., history or no history of heart failure, is needed, with a view to providing a reference for intervention measures in COVID-19 research. |
format | Online Article Text |
id | pubmed-9880207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98802072023-01-28 Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease Chen, Yiru Cao, Buzi Zhou, Quan Liu, Yantong He, Qingnan Zhao, Mingyi Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publications and used different types of software, such as R, CiteSpace, and VOSviewer, to analyze and visualize the data. RESULTS: A total of 10,055 publications were retrieved as of the 13 December 2022, based on the inclusion criteria after screening. The USA and China lead in the quantity and quality of publications in this field. Based on Bradford's law, 63 journals were considered core journals in the field. Co-cited references and keywords analysis indicated that researchers paid particular attention to cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. In summary, with increasing COVID-19 research related to CVD, more attention might be drawn to the relationship between these two diseases. CONCLUSION: The hotspots in this field may continue to revolve around cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. Owing to the different situations faced by different groups with COVID-19, further exploration of the related factors specific to each of these groups, e.g., history or no history of heart failure, is needed, with a view to providing a reference for intervention measures in COVID-19 research. Frontiers Media S.A. 2023-01-13 /pmc/articles/PMC9880207/ /pubmed/36712251 http://dx.doi.org/10.3389/fcvm.2022.1070336 Text en Copyright © 2023 Chen, Cao, Zhou, Liu, He and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Chen, Yiru Cao, Buzi Zhou, Quan Liu, Yantong He, Qingnan Zhao, Mingyi Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title | Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title_full | Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title_fullStr | Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title_full_unstemmed | Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title_short | Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease |
title_sort | bibliometric evaluation of 2020–2022 publications on covid-19-related cardiovascular disease |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880207/ https://www.ncbi.nlm.nih.gov/pubmed/36712251 http://dx.doi.org/10.3389/fcvm.2022.1070336 |
work_keys_str_mv | AT chenyiru bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease AT caobuzi bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease AT zhouquan bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease AT liuyantong bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease AT heqingnan bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease AT zhaomingyi bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease |